FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

John Kjekshus

Research Profile

Disorders

Chemicals & Drugs

Procedures

Concepts & Ideas

Geographic Areas

Scandinavia

Co-author Network

Publications

TOP 3
Jørgen Gravning; John Kjekshus; Lars Mørkrid; Torbjørn Omland; Helge Skulstad; Marit Kristine Smedsrud; Lars Aaberge; Bjørn Bendz; Christian Eek; Thor Edvardsen
Sensitive troponin assays and N-terminal pro-B-type natriuretic peptide in acute coronary syndrome: Prediction of significant coronary lesions and long-term prognosis.
Ana Cristina Perez; David Preiss; Pardeep S Jhund; John Kjekshus; John J V McMurray
Effect of rosuvastatin on fatigue in patients with heart failure.
Leeor M Jaffe; John Kjekshus; Stephen S Gottlieb
Importance and management of chronic sleep apnoea in cardiology.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of John Kjekshus (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Jørgen Gravning; John Kjekshus; Lars Mørkrid; Torbjørn Omland; Helge Skulstad; Marit Kristine Smedsrud; Lars Aaberge; Bjørn Bendz; Christian Eek; Thor Edvardsen
Sensitive troponin assays and N-terminal pro-B-type natriuretic peptide in acute coronary syndrome: Prediction of significant coronary lesions and long-term prognosis.
American heart journal 2013;165(5):716-24.
2013: Ana Cristina Perez; David Preiss; Pardeep S Jhund; John Kjekshus; John J V McMurray
Effect of rosuvastatin on fatigue in patients with heart failure.
Journal of the American College of Cardiology 2013;61(10):1121-2.
2013: Leeor M Jaffe; John Kjekshus; Stephen S Gottlieb
Importance and management of chronic sleep apnoea in cardiology.
European heart journal 2013;34(11):809-15.
2013: Erik Tandberg Askevold; Pål Aukrust; John G F Cleland; Jørgen Gravning; John Kjekshus; John J V McMurray; Ståle Nymo; Thor Ueland; Ragnhild Wergeland; Arne Yndestad; Lars Gullestad
Soluble glycoprotein 130 predicts fatal outcomes in chronic heart failure: analysis from the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA).
Circulation. Heart failure 2013;6(1):91-8.
2012: Lars Gullestad; Johannes Hulthe; John Kjekshus; John J V McMurray; Pieter Muntendam; Ståle H Nymo; Thor Ueland; John Wikstrand; Pål Aukrust
The predictive value of galectin-3 for mortality and cardiovascular events in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA).
American heart journal 2012;164(6):878-83.
2012: Jan Ivar Kåsin; John Kjekshus; Tor Ole Kjellevand; Geir B Nesheim; Anthony Wagstaff
CT examination of the pericardium and lungs in helicopter pilots exposed to vibration and noise.
Aviation, space, and environmental medicine 2012;83(9):858-64.
2012: Lars Gullestad; Johannes Hulthe; John Kjekshus; Michel Komajda; John J V McMurray; Pieter Muntendam; Ståle H Nymo; Thor Ueland; Dirk J van Veldhuisen; John Wikstrand; Aram Adourian; Pål Aukrust; Michael Böhm; John G F Cleland
Galectin-3 predicts response to statin therapy in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA).
European heart journal 2012;33(18):2290-6.
2012: David Preiss; Paul M Ridker; Naveed Sattar; Matti J Tikkanen; Paul Welsh; Michael J Murphy; Terje R Pedersen; Helen M Colhoun; David A DeMicco; Marshall B Elam; Ian Ford; Ilan Goldenberg; Anthony C Keech; John Kjekshus; John C LaRosa; Laura C Lovato; Thomas M MacDonald; John J V McMurray
Lipid-modifying therapies and risk of pancreatitis: a meta-analysis.
JAMA : the journal of the American Medical Association 2012;308(8):804-11.
2012: S H Nymo; Thor Ueland; D J Van Veldhuisen; J Wikstrand; E T Askevold; Pål Aukrust; Trude H Flo; Lars Gullestad; J Hulthe; John Kjekshus; J McMurray; Arne Yndestad
The association between neutrophil gelatinase-associated lipocalin and clinical outcome in chronic heart failure: results from CORONA*.
Journal of internal medicine 2012;271(5):436-43.
2012: Kaspar Broch; John G Cleland; Pål Aukrust; Johannes Hulthe; John Kjekshus; John J McMurray; Pieter Muntendam; Ståle H Nymo; Thor Ueland; John Wikstrand; Lars Gullestad
Soluble ST2 is associated with adverse outcome in patients with heart failure of ischaemic aetiology.
European journal of heart failure 2012;14(3):268-77.
2012: Arne Yndestad; Erik Oie; Øystein Sandanger; Geir Christensen; Christen P Dahl; Jan Kristian Damås; Kenneth Dickstein; Arnt E Fiane; Alexandra Vanessa Finsen; Lars Gullestad; Denise Hilfiker-Kleiner; Cathrine Husberg; John Kjekshus; Martin Lipp; Trine Ranheim; Ivar Sjaastad; Thor Ueland; Leif Erik Vinge; Pål Aukrust
The homeostatic chemokine CCL21 predicts mortality and may play a pathogenic role in heart failure.
PloS one 2012;7(3):e33038.
2011: Alberico L Catapano; Guy De Backer; Paul Durrington; Serap Erdine; Pasquale Perrone Filardi; Ian Graham; julian halcox; Richard Hobbs; John Kjekshus; Zeljko Reiner; Gabriele Riccardi; Robert F Storey; Marja-Riitta Taskinen; Olov Wiklund; David Wood; M John Chapman; Stefan Agewall; Eduardo Alegria
ESC/EAS Guidelines for the management of dyslipidaemias The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS).
Atherosclerosis 2011;217(1):3-46.
2011: Stefan Agewall; Eduardo Alegria; Alberico L Catapano; M John Chapman; Guy De Backer; Paul Durrington; Serap Erdine; Ian Graham; julian halcox; Richard Hobbs; John Kjekshus; Pasquale Perrone-Filardi; Zeljko Reiner; Gabriele Riccardi; Robert F Storey; Marja-Riitta Taskinen; Olov Wiklund; David Wood
ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS).
Atherosclerosis 2011;217 Suppl 1():S1-44.
2011: Thor Ueland; Christen P Dahl; John Kjekshus; Johannes Hulthe; Michael Böhm; François Mach; Assen Goudev; Magnus Lindberg; John Wikstrand; Pål Aukrust; Lars Gullestad
Osteoprotegerin predicts progression of chronic heart failure: results from CORONA.
Circulation. Heart failure 2011;4(2):145-52.
2010: John J V McMurray; Peter Dunselman; Hans Wedel; John G F Cleland; Magnus Lindberg; Ake Hjalmarson; John Kjekshus; Finn Waagstein; Eduard Apetrei; Vivencio Barrios; Michael Böhm; Gabriel Kamenský; Michel Komajda; Vyacheslav Mareev; John Wikstrand
Coenzyme Q10, rosuvastatin, and clinical outcomes in heart failure: a pre-specified substudy of CORONA (controlled rosuvastatin multinational study in heart failure).
Journal of the American College of Cardiology 2010;56(15):1196-204.
2010: Myung-A Kim; Dongheon Yang; Keisuke Kida; Natalia Molotkova; SJ Yeo; Nissi Varki; Michikado Iwata; Nancy D Dalton; Kirk L Peterson; Wolf-Eberhard Siems; Thomas Walther; Randy T Cowling; John Kjekshus; Barry Greenberg
Effects of ACE2 inhibition in the post-myocardial infarction heart.
Journal of cardiac failure 2010;16(9):777-85.
2010: Sally C Inglis; John J V McMurray; Michael Böhm; Maria Schaufelberger; Dirk J van Veldhuisen; Magnus Lindberg; Peter Dunselman; Ake Hjalmarson; John Kjekshus; Finn Waagstein; Hans Wedel; John Wikstrand
Intermittent claudication as a predictor of outcome in patients with ischaemic systolic heart failure: analysis of the Controlled Rosuvastatin Multinational Trial in Heart Failure trial (CORONA).
European journal of heart failure 2010;12(7):698-705.
2010: Rune Andersen; Torgeir Wethal; Anne Günther; Alexander Fosså; Thor Edvardsen; Sophie D Fosså; John Kjekshus
Relation of coronary artery calcium score to premature coronary artery disease in survivors >15 years of Hodgkin's lymphoma.
The American journal of cardiology 2010;105(2):149-52.
2010: PK Lorgelly; Andrew H Briggs; Hans Wedel; Peter Dunselman; Ake Hjalmarson; John Kjekshus; Finn Waagstein; John Wikstrand; András Jánosi; Dirk J van Veldhuisen; Vivencio Barrios; Cândida Fonseca; John J V McMurray
An economic evaluation of rosuvastatin treatment in systolic heart failure: evidence from the CORONA trial.
European journal of heart failure 2010;12(1):66-74.
2009: John J V McMurray; John Kjekshus; Lars Gullestad; Peter Dunselman; Ake Hjalmarson; Hans Wedel; Magnus Lindberg; Finn Waagstein; Peer Grande; Jaromir Hradec; Gabriel Kamenský; Jerzy Korewicki; Timo Kuusi; François Mach; Naresh Ranjith; John Wikstrand
Effects of statin therapy according to plasma high-sensitivity C-reactive protein concentration in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA): a retrospective analysis.
Circulation 2009;120(22):2188-96.
2009: John G F Cleland; John J V McMurray; John Kjekshus; Jan H Cornel; Peter Dunselman; Cândida Fonseca; Ake Hjalmarson; Jerzy Korewicki; Magnus Lindberg; Naresh Ranjith; Dirk J van Veldhuisen; Finn Waagstein; Hans Wedel; John Wikstrand
Plasma concentration of amino-terminal pro-brain natriuretic peptide in chronic heart failure: prediction of cardiovascular events and interaction with the effects of rosuvastatin: a report from CORONA (Controlled Rosuvastatin Multinational Trial in Heart Failure).
Journal of the American College of Cardiology 2009;54(20):1850-9.
2009: T Wethal; May Brit Lund; Thor Edvardsen; Sophie D Fosså; A H Pripp; Harald Holte; John Kjekshus; A Fosså
Valvular dysfunction and left ventricular changes in Hodgkin's lymphoma survivors. A longitudinal study.
British journal of cancer 2009;101(4):575-81.
2009: Janna Huskey; JoAnn Lindenfeld; Thomas Cook; Giovanni Targher; Jessica Kendrick; John Kjekshus; Terje Pedersen; Michel Chonchol
Effect of simvastatin on kidney function loss in patients with coronary heart disease: findings from the Scandinavian Simvastatin Survival Study (4S).
Atherosclerosis 2009;205(1):202-6.
2009: Stefan D Anker; Adriaan Voors; Darlington Okonko; Andrew L Clark; Margaret K James; Stephan von Haehling; John Kjekshus; Piotr Ponikowski; Kenneth Dickstein
Prevalence, incidence, and prognostic value of anaemia in patients after an acute myocardial infarction: data from the OPTIMAAL trial.
European heart journal 2009;30(11):1331-9.
2009: Jalal K Ghali; John Wikstrand; Dirk J van Veldhuisen; Björn Fagerberg; Sidney Goldstein; Ake Hjalmarson; Peter Johansson; John Kjekshus; Lis Ohlsson; Ola Samuelsson; Finn Waagstein; Hans Wedel
The influence of renal function on clinical outcome and response to beta-blockade in systolic heart failure: insights from Metoprolol CR/XL Randomized Intervention Trial in Chronic HF (MERIT-HF).
Journal of cardiac failure 2009;15(4):310-8.
2009: Arne Yndestad; Linn Landrø; Thor Ueland; Christen P Dahl; Trude H Flo; Leif Erik Vinge; Terje Espevik; Stig S Frøland; Cathrine Husberg; Geir Christensen; Kenneth Dickstein; John Kjekshus; Erik Øie; Lars Gullestad; Pål Aukrust
Increased systemic and myocardial expression of neutrophil gelatinase-associated lipocalin in clinical and experimental heart failure.
European heart journal 2009;30(10):1229-36.
2009: Hans Wedel; John J V McMurray; Magnus Lindberg; John Wikstrand; John G F Cleland; Jan H Cornel; Peter Dunselman; Ake Hjalmarson; John Kjekshus; Michel Komajda; Timo Kuusi; Johan Vanhaecke; Finn Waagstein
Predictors of fatal and non-fatal outcomes in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA): incremental value of apolipoprotein A-1, high-sensitivity C-reactive peptide and N-terminal pro B-type natriuretic peptide.
European journal of heart failure 2009;11(3):281-91.
2009: Jan Ivar Kåsin; John Kjekshus; Pål Aukrust; Tom Eirik Mollnes; Anthony Wagstaff
A helicopter flight does not induce significant changes in systemic biomarker profiles.
Scandinavian journal of clinical and laboratory investigation 2009;69(4):462-74.
2008: Jørgen Gravning; John Kjekshus
The perfect biomarker in acute coronary syndrome: a challenge for diagnosis, prognosis, and treatment.
European heart journal 2008;29(23):2827-8.
2008: Jørgen Gravning; Thor Ueland; Lars Mørkrid; Knut Endresen; Lars Aaberge; John Kjekshus
Different prognostic importance of elevated troponin I after percutaneous coronary intervention in acute coronary syndrome and stable angina pectoris.
Scandinavian cardiovascular journal : SCJ 2008;42(3):214-21.
2008: John Kjekshus
What are the effects of patient age and blood pressure on the cholesterol-related risk of vascular mortality?
Nature clinical practice. Cardiovascular medicine 2008;5(6):310-1.
2007: John Kjekshus; Eduard Apetrei; Vivencio Barrios; Michael Böhm; John G F Cleland; Jan H Cornel; Peter H J M Dunselman; Cândida Fonseca; Assen R Goudev; Peer Grande; Lars Gullestad; Ake Hjalmarson; Jaromir Hradec; András Jánosi; Gabriel Kamenský; Michel Komajda; Jerzy Korewicki; Timo Kuusi; François Mach; Vyacheslav Mareev; john mcmurray; Naresh Ranjith; Maria Schaufelberger; Johan Vanhaecke; Dirk J van Veldhuisen; Finn Waagstein; Hans Wedel; John Wikstrand
Rosuvastatin in older patients with systolic heart failure.
The New England journal of medicine 2007;357(22):2248-61.
2007: T Wethal; John Kjekshus; Jo Røislien; Thor Ueland; Arne K Andreassen; Ragnhild Wergeland; Pål Aukrust; Sophie D Fosså
Treatment-related differences in cardiovascular risk factors in long-term survivors of testicular cancer.
Journal of cancer survivorship : research and practice 2007;1(1):8-16.
2007: Jan Kristian Damås; Camilla Smith; Erik Øie; Børre Fevang; Bente Halvorsen; Torgun Waehre; Agnès Boullier; Unni Breland; Arne Yndestad; Olga Ovchinnikova; Anna-Karin L Robertson; Wiggo J Sandberg; John Kjekshus; Kjetil Taskén; Stig S Frøland; Lars Gullestad; Göran K Hansson; Oswald Quehenberger; Pål Aukrust
Enhanced expression of the homeostatic chemokines CCL19 and CCL21 in clinical and experimental atherosclerosis: possible pathogenic role in plaque destabilization.
Arteriosclerosis, thrombosis, and vascular biology 2007;27(3):614-20.
2006: Mette Elise Estensen; Aina Hognestad; Unni Syversen; Iain Squire; Leong Ng; John Kjekshus; Kenneth Dickstein; Torbjørn Omland
Prognostic value of plasma chromogranin A levels in patients with complicated myocardial infarction.
American heart journal 2006;152(5):927.e1-6.
2006: Thor Ueland; Terje Espevik; John Kjekshus; Lars Gullestad; Torbjørn Omland; Iain B Squire; Stig S Frøland; Tom Eirik Mollnes; Kenneth Dickstein; Pål Aukrust
Mannose binding lectin and soluble Toll-like receptor 2 in heart failure following acute myocardial infarction.
Journal of cardiac failure 2006;12(8):659-63.
2006: Dirk J van Veldhuisen; Halfdan Aass; Dia el Allaf; Peter H J M Dunselman; Lars Gullestad; Matti Halinen; John Kjekshus; Lis Ohlsson; Hans Wedel; John Wikstrand
Presence and development of atrial fibrillation in chronic heart failure. Experiences from the MERIT-HF Study.
European journal of heart failure 2006;8(5):539-46.
2006: Bjarne A Waaler; Jonny Hisdal; Halfdan Ihlen; John Kjekshus
Mechanisms behind the postprandial increase in cardiac output: a clue obtained from transplanted hearts.
European journal of applied physiology 2006;97(5):516-20.
2006: Torbjørn Holm; Thor Ueland; Bente Halvorsen; Aina Hognestad; Anne G V Holm; Ragnhild Wergeland; Lars Gullestad; Pål Aukrust; John Kjekshus
A protective anti-inflammatory phenotype in high-risk individuals who do not develop coronary artery disease.
Journal of the American College of Cardiology 2006;47(5):1085-6.
2005: Thor Ueland; John Kjekshus; Stig S Frøland; Torbjørn Omland; Iain B Squire; Lars Gullestad; Kenneth Dickstein; Pål Aukrust
Plasma levels of soluble tumor necrosis factor receptor type I during the acute phase following complicated myocardial infarction predicts survival in high-risk patients.
Journal of the American College of Cardiology 2005;46(11):2018-21.
2005: Lars Gullestad; Thor Ueland; Jan G Fjeld; Even Holt; Torstein Gundersen; Kjell Breivik; Magne Følling; Anders Hodt; Rita Skårdal; John Kjekshus; Arne K Andreassen; Elin Kjekshus; Ragnhild Wergeland; Arne Yndestad; Stig S Frøland; Anne G Semb; Pål Aukrust
Effect of thalidomide on cardiac remodeling in chronic heart failure: results of a double-blind, placebo-controlled study.
Circulation 2005;112(22):3408-14.
2005: John Kjekshus; Peter H J M Dunselman; Malin Blideskog; Christina Eskilson; Ake Hjalmarson; John V McMurray; Finn Waagstein; Hans Wedel; Peter Wessman; John Wikstrand
A statin in the treatment of heart failure? Controlled rosuvastatin multinational study in heart failure (CORONA): study design and baseline characteristics.
European journal of heart failure 2005;7(6):1059-69.
2005: Aina Hognestad; Torbjørn Holm; Svein Simonsen; John Kjekshus; Arne K Andreassen
Serial measurements of peripheral vascular reactivity and exercise capacity in congestive heart failure and after heart transplantation.
Journal of cardiac failure 2005;11(6):447-54.
2005: Aina Hognestad; Knut Endresen; Ragnhild Wergeland; Jan R Mellembakken; Tom Eirik Mollnes; Torbjørn Omland; John Kjekshus; Pål Aukrust; Arne K Andreassen
Inflammatory response and re-stenosis after percutaneous coronary intervention in heart transplant recipients and patients with native atherosclerosis.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 2005;24(8):1026-32.
2005: Thor Ueland; Pål Aukrust; Arne Yndestad; Kari Otterdal; Stig S Frøland; Kenneth Dickstein; John Kjekshus; Lars Gullestad; Jan Kristian Damås
Soluble CD40 ligand in acute and chronic heart failure.
European heart journal 2005;26(11):1101-7.
2005: Lars Gullestad; John Kjekshus; Jan Kristian Damås; Thor Ueland; Arne Yndestad; Pål Aukrust
Agents targeting inflammation in heart failure.
Expert opinion on investigational drugs 2005;14(5):557-66.
2005: Lars Gullestad; John Wikstrand; Prakash Deedwania; Ake Hjalmarson; Kenneth Egstrup; Uri Elkayam; Stephen S Gottlieb; Andrew Rashkow; Hans Wedel; Georgina Bermann; John Kjekshus
What resting heart rate should one aim for when treating patients with heart failure with a beta-blocker? Experiences from the Metoprolol Controlled Release/Extended Release Randomized Intervention Trial in Chronic Heart Failure (MERIT-HF).
Journal of the American College of Cardiology 2005;45(2):252-9.
2005: Prakash C Deedwania; Thomas D Giles; Michael Klibaner; Jalal K Ghali; Johan Herlitz; Per Hildebrandt; John Kjekshus; Jindrich Spinar; Jiri Vitovec; Hilary Stanbrook; John Wikstrand
Efficacy, safety and tolerability of metoprolol CR/XL in patients with diabetes and chronic heart failure: experiences from MERIT-HF.
American heart journal 2005;149(1):159-67.
2004: Thor Ueland; Rune Jemtland; Kristin Godang; John Kjekshus; Aina Hognestad; Torbjørn Omland; Iain B Squire; Lars Gullestad; Jens Bollerslev; Kenneth Dickstein; Pål Aukrust
Prognostic value of osteoprotegerin in heart failure after acute myocardial infarction.
Journal of the American College of Cardiology 2004;44(10):1970-6.
2004: Terje R Pedersen; Anders G Olsson; Ole Faergeman; John Kjekshus; Hans Wedel; Kåre Berg; Lars Wilhelmsen; Torben Haghfelt; Gudmundur Thorgeirsson; Kalevi Pyörälä; Tatu A Miettinen; Bjørn Christophersen; Jonathan A Tobert; Thomas A Musliner; Thomas J Cook
Lipoprotein changes and reduction in the incidence of major coronary heart disease events in the Scandinavian Simvastatin Survival Study (4S). 1998.
Atherosclerosis. Supplements 2004;5(3):99-106.
2004: Timo E Strandberg; Kalevi Pyörälä; Thomas J Cook; Lars Wilhelmsen; Ole Faergeman; Gudmundur Thorgeirsson; Terje R Pedersen; John Kjekshus
Mortality and incidence of cancer during 10-year follow-up of the Scandinavian Simvastatin Survival Study (4S).
Lancet 2004;364(9436):771-7.
2004: Aina Hognestad; Pål Aukrust; Ragnhild Wergeland; Oddvar Stokke; Lars Gullestad; Anne G Semb; Torbjørn Holm; Arne K Andreassen; John Kjekshus
Effects of conventional and aggressive statin treatment on markers of endothelial function and inflammation.
Clinical cardiology 2004;27(4):199-203.
2004: Aina Hognestad; Annika E Michelsen; Frank Brosstad; Jan Kristian Damås; Torbjørn Holm; Svein Simonsen; John Kjekshus; Pål Aukrust; Arne K Andreassen
Platelet activation in heart transplant recipients.
Clinical transplantation 2004;18(2):142-7.
2004: Aina Hognestad; Kenneth Dickstein; Eivind Myhre; Steven M Snapinn; John Kjekshus
Effect of combined statin and beta-blocker treatment on one-year morbidity and mortality after acute myocardial infarction associated with heart failure.
The American journal of cardiology 2004;93(5):603-6.
2004: Lars Gullestad; Jonathan Myers; Thor Edvardsen; John Kjekshus; Odd Geiran; Svein Simonsen
Predictors of exercise capacity and the impact of angiographic coronary artery disease in heart transplant recipients.
American heart journal 2004;147(1):49-54.
2003: Peter H J M Dunselman; Ake Hjalmarson; John Kjekshus; John McMurray; Finn Waagstein
The statin wars.
Lancet 2003;362(9398):1854; discussion 1856.
2003: John Wikstrand; Hans Wedel; Jalal K Ghali; Prakash Deedwania; Björn Fagerberg; Sidney Goldstein; Stephen S Gottlieb; Ake Hjalmarson; John Kjekshus; Finn Waagstein
How should subgroup analyses affect clinical practice? Insights from the Metoprolol Succinate Controlled-Release/Extended-Release Randomized Intervention Trial in Heart Failure (MERIT-HF).
Cardiac electrophysiology review 2003;7(3):264-75.
2003: Aina Hognestad; Knut Endresen; Ragnhild Wergeland; Oddvar Stokke; Odd Geiran; Torbjørn Holm; Svein Simonsen; John Kjekshus; Arne K Andreassen
Plasma C-reactive protein as a marker of cardiac allograft vasculopathy in heart transplant recipients.
Journal of the American College of Cardiology 2003;42(3):477-82.
2003: Christian Hall; Halfdan Ihlen; Vernon Bonarjee; Kenneth Dickstein; John Kjekshus
N-terminal proatrial natriuretic peptide in primary care: relation to echocardiographic indices of cardiac function in mild to moderate cardiac disease.
International journal of cardiology 2003;89(2-3):197-205.
2003: Torbjørn Holm; Jan Kristian Damås; Kirsten B Holven; I Nordøy; Frank Brosstad; Thor Ueland; T Währe; John Kjekshus; Stig S Frøland; Hans Geir Eiken; Nils Olav Solum; Lars Gullestad; Marit S Nenseter; Pål Aukrust
CXC-chemokines in coronary artery disease: possible pathogenic role of interactions between oxidized low-density lipoprotein, platelets and peripheral blood mononuclear cells.
Journal of thrombosis and haemostasis : JTH 2003;1(2):257-62.
2002: Torbjørn Holm; Pål Aukrust; Erik Aagaard; Thor Ueland; Tor S. Haugstad; John Kjekshus; Svein Simonsen; Stig S Frøland; Lars Gullestad; Arne K Andreassen
Hypertension in relation to nitric oxide, asymmetric dimethylarginine, and inflammation: different patterns in heart transplant recipients and individuals with essential hypertension.
Transplantation 2002;74(10):1395-400.
2002: Torgun Waehre; Bente Halvorsen; Jan Kristian Damås; Arne Yndestad; Frank Brosstad; Lars Gullestad; John Kjekshus; Stig S Frøland; Pål Aukrust
Inflammatory imbalance between IL-10 and TNFalpha in unstable angina potential plaque stabilizing effects of IL-10.
European journal of clinical investigation 2002;32(11):803-10.
2002: John Wikstrand; Ake Hjalmarson; Finn Waagstein; Björn Fagerberg; Sidney Goldstein; John Kjekshus; Hans Wedel
Dose of metoprolol CR/XL and clinical outcomes in patients with heart failure: analysis of the experience in metoprolol CR/XL randomized intervention trial in chronic heart failure (MERIT-HF).
Journal of the American College of Cardiology 2002;40(3):491-8.
2002: Wei Qi; Per Mathisen; John Kjekshus; Svein Simonsen; Knut Endresen; Reidar Bjørnerheim; Christian Hall
The effect of aortic valve replacement on N-terminal natriuretic propeptides in patients with aortic stenosis.
Clinical cardiology 2002;25(4):174-80.
2002: Stephen S Gottlieb; Michael L Fisher; John Kjekshus; Prakash Deedwania; Lars Gullestad; Jiri Vitovec; John Wikstrand
Tolerability of beta-blocker initiation and titration in the Metoprolol CR/XL Randomized Intervention Trial in Congestive Heart Failure (MERIT-HF).
Circulation 2002;105(10):1182-8.
2001: Christie M Ballantyne; Anders G Olsson; Thomas J Cook; M F Mercuri; Terje R Pedersen; John Kjekshus
Influence of low high-density lipoprotein cholesterol and elevated triglyceride on coronary heart disease events and response to simvastatin therapy in 4S.
Circulation 2001;104(25):3046-51.
2001: W Qi; P Mathisen; John Kjekshus; Svein Simonsen; Reidar Bjørnerheim; Knut Endresen; Christian Hall
Natriuretic peptides in patients with aortic stenosis.
American heart journal 2001;142(4):725-32.
2001: Hans Wedel; D Demets; Prakash Deedwania; Björn Fagerberg; Sidney Goldstein; Stephen S Gottlieb; Ake Hjalmarson; John Kjekshus; Finn Waagstein; John Wikstrand
Challenges of subgroup analyses in multinational clinical trials: experiences from the MERIT-HF trial.
American heart journal 2001;142(3):502-11.
2001: Torbjørn Holm; Rolf K Berge; Arne K Andreassen; Thor Ueland; John Kjekshus; Svein Simonsen; Stig S Frøland; Lars Gullestad; Pål Aukrust
Omega-3 fatty acids enhance tumor necrosis factor-alpha levels in heart transplant recipients.
Transplantation 2001;72(4):706-11.
2001: Lars Gullestad; Cord Manhenke; Torbjørn Aarsland; Rita Skårdal; H Fagertun; J Wikstrand; John Kjekshus
Effect of metoprolol CR/XL on exercise tolerance in chronic heart failure - a substudy to the MERIT-HF trial.
European journal of heart failure 2001;3(4):463-8.
2001: Lars Gullestad; Halfdan Aass; Arne K Andreassen; Halfdan Ihlen; Svein Simonsen; John Kjekshus; L Wikeby; Sigurd Nitter-Hauge; Jan G Fjeld; Egil Lien; Thor Ueland; Stig S Frøland; Pål Aukrust
[Immunomodulating treatment in advanced heart failure--effect of intravenous immunoglobulin].
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 2001;121(16):1902-7.
2001: Torbjørn Holm; Arne K Andreassen; Thor Ueland; John Kjekshus; Stig S Frøland; Elin Kjekshus; Svein Simonsen; Pål Aukrust; Lars Gullestad
Effect of pravastatin on plasma markers of inflammation and peripheral endothelial function in male heart transplant recipients.
The American journal of cardiology 2001;87(6):815-8, A9.
2001: Torbjørn Holm; Arne K Andreassen; Pål Aukrust; K Andersen; Odd Geiran; John Kjekshus; Svein Simonsen; Lars Gullestad
Omega-3 fatty acids improve blood pressure control and preserve renal function in hypertensive heart transplant recipients.
European heart journal 2001;22(5):428-36.
2001: Lars Gullestad; Halfdan Aass; Jan G Fjeld; L Wikeby; Arne K Andreassen; Halfdan Ihlen; Svein Simonsen; John Kjekshus; Sigurd Nitter-Hauge; Thor Ueland; Egil Lien; Stig S Frøland; Pål Aukrust
Immunomodulating therapy with intravenous immunoglobulin in patients with chronic heart failure.
Circulation 2001;103(2):220-5.
2000: Terje R Pedersen; Lars Wilhelmsen; Ole Faergeman; Timo E Strandberg; Gudmundur Thorgeirsson; L Troedsson; J Kristianson; Kåre Berg; Thomas J Cook; Torben Haghfelt; John Kjekshus; Tatu A Miettinen; Anders G Olsson; Kalevi Pyörälä; Hans Wedel
Follow-up study of patients randomized in the Scandinavian simvastatin survival study (4S) of cholesterol lowering.
The American journal of cardiology 2000;86(3):257-62.
2000: W Qi; Harald Kjekshus; RF Klinge; John Kjekshus; Christian Hall
Cardiac natriuretic peptides and continuously monitored atrial pressures during chronic rapid pacing in pigs.
Acta physiologica Scandinavica 2000;169(2):95-102.
2000: Ake Hjalmarson; Sidney Goldstein; Björn Fagerberg; Hans Wedel; Finn Waagstein; John Kjekshus; John Wikstrand; Dia el Allaf; J Vítovec; J Aldershvile; Matti Halinen; R Dietz; K L Neuhaus; András Jánosi; Gudmundur Thorgeirsson; Peter H J M Dunselman; Lars Gullestad; J Kuch; Johan Herlitz; P Rickenbacher; S Ball; Stephen S Gottlieb; Prakash Deedwania
Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group.
JAMA : the journal of the American Medical Association 2000;283(10):1295-302.
2000: W Qi; John Kjekshus; Christian Hall
Differential responses of plasma atrial and brain natriuretic peptides to acute alteration in atrial pressure in pigs.
Scandinavian journal of clinical and laboratory investigation 2000;60(1):55-63.
1999: Steven M Haffner; Charles M Alexander; Thomas J Cook; Steve J Boccuzzi; Thomas A Musliner; Terje R Pedersen; John Kjekshus; Kalevi Pyörälä
Reduced coronary events in simvastatin-treated patients with coronary heart disease and diabetes or impaired fasting glucose levels: subgroup analyses in the Scandinavian Simvastatin Survival Study.
Archives of internal medicine 1999;159(22):2661-7.
1999: William H Herman; Charles M Alexander; John R Cook; Steve J Boccuzzi; Thomas A Musliner; Terje R Pedersen; John Kjekshus; Kalevi Pyörälä
Effect of simvastatin treatment on cardiovascular resource utilization in impaired fasting glucose and diabetes. Findings from the Scandinavian Simvastatin Survival Study.
Diabetes care 1999;22(11):1771-8.
1999: Lars Gullestad; Reidar Bjørnerheim; Jon Offstad; Knut Endresen; Kolbjørn Forfang; John Kjekshus; V Hansteen
[Current use of beta-blockers in coronary artery disease].
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 1999;119(1):24-8.
1999: Karl Swedberg; John Kjekshus; S Snapinn
Long-term survival in severe heart failure in patients treated with enalapril. Ten year follow-up of CONSENSUS I.
European heart journal 1999;20(2):136-9.
1998: RF Klinge; Marit E Hystad; John Kjekshus; B E Karlberg; O Djøseland; A Aakvaag; Christian Hall
An experimental study of cardiac natriuretic peptides as markers of development of congestive heart failure.
Scandinavian journal of clinical and laboratory investigation 1998;58(8):683-91.
1998: Ole Faergeman; John Kjekshus; T Cook; Kalevi Pyörälä; Lars Wilhelmsen; Gudmundur Thorgeirsson; Terje R Pedersen
Differences in the treatment of coronary heart disease between countries as revealed in the Scandinavian Simvastatin Survival Study (4S)
European heart journal 1998;19(10):1531-7.
1998: SK Braekken; Knut Endresen; David Russell; Rainer Brucher; John Kjekshus
Influence of guidewire and catheter type on the frequency of cerebral microembolic signals during left heart catheterization.
The American journal of cardiology 1998;82(5):632-7.
1998: Arne K Andreassen; Knut Kvernebo; B Jørgensen; Svein Simonsen; John Kjekshus; Lars Gullestad
Exercise capacity in heart transplant recipients: relation to impaired endothelium-dependent vasodilation of the peripheral microcirculation.
American heart journal 1998;136(2):320-8.
1998: Terje R Pedersen; Anders G Olsson; Ole Faergeman; John Kjekshus; Hans Wedel; Kåre Berg; Lars Wilhelmsen; Torben Haghfelt; Gudmundur Thorgeirsson; Kalevi Pyörälä; Tatu A Miettinen; B Christophersen; Jonathan A Tobert; Thomas A Musliner; Thomas J Cook
Lipoprotein changes and reduction in the incidence of major coronary heart disease events in the Scandinavian Simvastatin Survival Study (4S)
Circulation 1998;97(15):1453-60.
1998: Pål Aukrust; Thor Ueland; Fredrik Müller; Arne K Andreassen; I Nordøy; H Aas; John Kjekshus; Svein Simonsen; Stig S Frøland; Lars Gullestad
Elevated circulating levels of C-C chemokines in patients with congestive heart failure.
Circulation 1998;97(12):1136-43.
1998: Olaf Rodevand; R Bjornerheim; svend aakhus; John Kjekshus
Left ventricular volumes assessed by different new three-dimensional echocardiographic methods and ordinary biplane technique.
International journal of cardiac imaging 1998;14(1):55-63.
1998: Terje R Pedersen; John Kjekshus; Kalevi Pyörälä; Anders G Olsson; Thomas J Cook; Thomas A Musliner; Jonathan A Tobert; Torben Haghfelt
Effect of simvastatin on ischemic signs and symptoms in the Scandinavian simvastatin survival study (4S).
The American journal of cardiology 1998;81(3):333-5.
1997: Tatu A Miettinen; Kalevi Pyörälä; Anders G Olsson; Thomas A Musliner; Thomas J Cook; Ole Faergeman; Kåre Berg; T Pedersen; John Kjekshus
Cholesterol-lowering therapy in women and elderly patients with myocardial infarction or angina pectoris: findings from the Scandinavian Simvastatin Survival Study (4S)
Circulation 1997;96(12):4211-8.
1997: John Kjekshus; Terje R Pedersen; Anders G Olsson; Ole Faergeman; Kalevi Pyörälä
The effects of simvastatin on the incidence of heart failure in patients with coronary heart disease.
Journal of cardiac failure 1997;3(4):249-54.
1997: Kåre Berg; G Dahlén; Bjørn O Christophersen; T Cook; John Kjekshus; T Pedersen
Lp(a) lipoprotein level predicts survival and major coronary events in the Scandinavian Simvastatin Survival Study.
Clinical genetics 1997;52(5):254-61.
1997: Olaf Rodevand; R Bjornerheim; O Kolbjornsen; Halfdan Ihlen; John Kjekshus
Left ventricular mass assessed by three-dimensional echocardiography using rotational acquisition.
Clinical cardiology 1997;20(11):957-62.
1997: E Aaser; Lars Gullestad; Stein Tølløfsrud; J Lundberg; Christian Hall; O Djøseland; John Kjekshus; Kolbjørn Forfang
Effect of bolus injection versus continuous infusion of furosemide on diuresis and neurohormonal activation in patients with severe congestive heart failure.
Scandinavian journal of clinical and laboratory investigation 1997;57(4):361-7.
1997: Lars Gullestad; J Myers; R Bjornerheim; Knut Joachim Berg; O Djoseland; Christian Hall; Kirsten Lund; John Kjekshus; Svein Simonsen
Gas exchange and neurohumoral response to exercise: influence of the exercise protocol.
Medicine and science in sports and exercise 1997;29(4):496-502.
1997: K Pyŏrälä; Terje R Pedersen; John Kjekshus; Ole Faergeman; Anders G Olsson; Gudmundur Thorgeirsson
Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S)
Diabetes care 1997;20(4):614-20.
1997: K N Nguyen; Ivar Aursnes; John Kjekshus
Interaction between enalapril and aspirin on mortality after acute myocardial infarction: subgroup analysis of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II)
The American journal of cardiology 1997;79(2):115-9.
1997: Allan D Sniderman; T Pedersen; John Kjekshus
Putting low-density lipoproteins at center stage in atherogenesis.
The American journal of cardiology 1997;79(1):64-7.
1996: John Kjekshus; O Faergeman
[Reduction of cholesterol prevents disease].
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 1996;116(28):3319-20.
1996: Lars Gullestad; G Haywood; Heather Ross; R Bjornerheim; Odd Geiran; John Kjekshus; Svein Simonsen; Michael Fowler
Exercise capacity of heart transplant recipients: the importance of chronotropic incompetence.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 1996;15(11):1075-83.
1996: Terje R Pedersen; Kåre Berg; Thomas J Cook; Ole Faergeman; Torben Haghfelt; John Kjekshus; Tatu A Miettinen; Thomas A Musliner; Anders G Olsson; Kalevi Pyörälä; Gudmundur Thorgeirsson; Jonathan A Tobert; H Wedel; Lars Wilhelmsen
Safety and tolerability of cholesterol lowering with simvastatin during 5 years in the Scandinavian Simvastatin Survival Study.
Archives of internal medicine 1996;156(18):2085-92.
1996: John Kjekshus; Terje R Pedersen; Jonathan A Tobert
Lipid-lowering therapy for patients with or at risk of coronary artery disease.
Current opinion in cardiology 1996;11(4):418-27.
1996: Terje R Pedersen; John Kjekshus; Kåre Berg; Anders G Olsson; Lars Wilhelmsen; H Wedel; Kalevi Pyörälä; Tatu A Miettinen; Torben Haghfelt; Ole Faergeman; Gudmundur Thorgeirsson; B Jönsson; J S Schwartz
Cholesterol lowering and the use of healthcare resources. Results of the Scandinavian Simvastatin Survival Study.
Circulation 1996;93(10):1796-802.
1996: Lars Gullestad; J Myers; H Noddeland; Reidar Bjørnerheim; O Djøseland; Christian Hall; O Gieran; John Kjekshus; Svein Simonsen
Influence of the exercise protocol on hemodynamic, gas exchange, and neurohumoral responses to exercise in heart transplant recipients.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 1996;15(3):304-13.
1995: Arne K Andreassen; Lars Gullestad; Reidar Bjørnerheim; Kolbjørn Forfang; John Kjekshus
[Intermittent claudication and beta-blockaders. An unfortunate combination?].
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 1995;115(6):725-8.
1995: Lars Gullestad; S Simonsen; John Kjekshus
[Reduced physical tolerance in patients with heart failure. Mechanisms and therapeutic effects].
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 1995;115(1):38-42.
1994: John Kjekshus
[Treatment of heart failure--life and doctrine].
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 1994;114(21):2471-2.
1994: Christian Hall; John Kjekshus; P Eneroth; S Snapinn
The plasma concentration of N-terminal proatrial natriuretic factor ANF(1-98) is related to prognosis in severe heart failure.
Clinical cardiology 1994;17(4):191-5.
1992: Lars Gullestad; John Kjekshus
[Sudden cardiac death. Significance of beta blockaders].
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 1992;112(22):2843-7.
1992: John Kjekshus
[Treatment of chronic heart failure].
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 1992;112(17):2177-8.
1992: Lars Gullestad; John Kjekshus
[Myocardial disease in diabetes mellitus].
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 1992;112(8):1016-9.
1988: Christian Hall; Lars Mørkrid; John Kjekshus
Redistribution of peripheral blood flow during acute left ventricular failure in the dog.
Scandinavian journal of clinical and laboratory investigation 1988;48(8):785-94.
1987: P Grøttum; M Sederholm; John Kjekshus
Quantitative and temporal relation between the release of myoglobin and creatine kinase and the evolution of vectorcardiographic changes during acute myocardial infarction in man.
Cardiovascular research 1987;21(9):652-9.
1987: C Risøe; O J Kirkeby; P Grøttum; M Sederholm; John Kjekshus
Fever after acute myocardial infarction in patients treated with intravenous timolol or placebo.
British heart journal 1987;57(1):28-31.
1986: P Grøttum; John Kjekshus
A comparison of cumulated CK release with three vectorcardiographic methods of estimating myocardial infarct size.
Journal of electrocardiology 1986;19(4):337-45.
1986: T Gundersen; P Grøttum; T Pedersen; John Kjekshus
Effect of timolol on mortality and reinfarction after acute myocardial infarction: prognostic importance of heart rate at rest.
The American journal of cardiology 1986;58(1):20-4.
1986: P Grøttum; B Mohr; John Kjekshus
Evolution of vectorcardiographic QRS changes during myocardial infarction in dogs and their relation to infarct size.
Cardiovascular research 1986;20(2):108-16.
1985: M Sederholm; P Grøttum; John Kjekshus; L Erhardt
Course of chest pain and its relation to CK release and ST/QRS vector changes in patients with acute myocardial infarction randomized to treatment with intravenous timolol or placebo.
American heart journal 1985;110(3):521-8.
1985: Jan Erik Nordrehaug; K A Johannessen; G von der Lippe; M Sederholm; P Grøttum; John Kjekshus
Effect of timolol on changes in serum potassium concentration during acute myocardial infarction.
British heart journal 1985;53(4):388-93.
1983: M Sederholm; P Grøttum; L Erhardt; John Kjekshus
Quantitative assessment of myocardial ischemia and necrosis by continuous vectorcardiography and measurement of creatine kinase release in patients.
Circulation 1983;68(5):1006-12.
1981: John Kjekshus; Arnoldus Blix; P Grøttum; A O Aasen
Beneficial effects of vagal stimulation on the ischaemic myocardium during beta-receptor blockade.
Scandinavian journal of clinical and laboratory investigation 1981;41(4):383-9.